Published in Biochemistry on February 10, 1987
Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Invest New Drugs (1997) 0.93
The reaction of platinum(II) complexes with DNA. Kinetics of intrastrand crosslink formation in vitro. Nucleic Acids Res (1991) 0.91
Reactivity of monofunctional cis-platinum adducts as a function of DNA sequence. Nucleic Acids Res (1988) 0.88
Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin. World J Gastroenterol (2010) 0.83
Analysis of heat-labile sites generated by reactions of depleted uranium and ascorbate in plasmid DNA. J Biol Inorg Chem (2013) 0.77
Monofunctional DNA-platinum(II) adducts block frequently DNA polymerases. Nucleic Acids Res (1992) 0.76
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood (1995) 5.34
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood (1990) 3.50
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant (2011) 1.85
Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet (1985) 1.66
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells. Ann Neurol (1995) 1.50
Catabolism of diadenosine 5',5"'-P1,P4-tetraphosphate in procaryotes. Purification and properties of diadenosine 5',5"'-P1,P4-tetraphosphate (symmetrical) pyrophosphohydrolase from Escherichia coli K12. J Biol Chem (1983) 1.49
Mechanism of synthesis of adenosine(5')tetraphospho(5')adenosine (AppppA) by aminoacyl-tRNA synthetases. Eur J Biochem (1982) 1.42
Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood (1995) 1.28
L-phenylalanyl-tRNA synthetase of Escherichia coli K-10. A reinvestigation of molecular weight and subunit structure. Eur J Biochem (1974) 1.22
Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J Immunol (2000) 1.21
Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant (2001) 1.20
Reaction of N-acetylglucosamine oligosaccharides with lysozyme. Temperature, pH, and solvent deuterium isotope effects; equilbrium, steady state, and pre-steady state measurements*. J Biol Chem (1975) 1.20
Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant (2004) 1.17
Synthesis of diadenosine 5',5'''-P1,P4-tetraphosphate (AppppA) from adenosine 5'-phosphosulfate and adenosine 5'-triphosphate catalyzed by yeast AppppA phosphorylase. Biochemistry (1988) 1.14
Productive and unproductive lysozyme-chitosaccharide complexes. Equilibrium measurements. Biochemistry (1975) 1.13
On the active site topography of isoleucyl transfer ribonucleic acid synthetase of Escherichia coli B. Biochemistry (1973) 1.13
Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor. Bone Marrow Transplant (2012) 1.11
Kinetics of lysozyme-substrate interactions. Biochem Biophys Res Commun (1969) 1.11
Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J Viral Hepat (2007) 1.10
Acute pneumatosis cystoides intestinalis following allogeneic transplantation -- the surgeon's dilemma. Bone Marrow Transplant (2002) 1.09
Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood (1997) 1.07
Lambda-chain production in human lymphoblast-mouse fibroblast hybrids. Proc Natl Acad Sci U S A (1973) 1.06
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease. Blood (1992) 1.04
Polymorphisms of cytokine and innate immunity genes and GVHD. Best Pract Res Clin Haematol (2008) 1.01
Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant (2006) 0.96
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplant (2005) 0.96
Isoleucyl transfer ribonucleic acid synthetase of Escherichia coli B. A rapid kinetic investigation of the L-isoleucine-activating reaction. Biochemistry (1972) 0.96
Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor. Blood (1989) 0.95
Structure-function analysis of mononucleotides and short oligonucleotides in the priming of enzymatic DNA synthesis. Biochemistry (1990) 0.95
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant (2003) 0.94
Circular dichroism and ordered structure of bisnucleoside oligophosphates and their Zn2+ and Mg2+ complexes. Biochemistry (1983) 0.94
Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit. Mycoses (2011) 0.93
An unusual polyanion from Physarum polycephalum that inhibits homologous DNA polymerase alpha in vitro. Biochemistry (1989) 0.93
Analysis of the genome of molluscum contagiosum virus by restriction endonuclease analysis and molecular cloning. J Med Virol (1986) 0.93
Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease. Genes Immun (2009) 0.93
Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res (1996) 0.93
2-p-Toluidinylnaphthalene-6-sulfonate, a fluorescent reporter group for L-isoleucyl-tRNA synthetase. Biochem Biophys Res Commun (1971) 0.93
Adoptive immunotherapy with donor lymphocyte transfusions. Curr Opin Oncol (1997) 0.93
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. Bone Marrow Transplant (2005) 0.92
Specificity and direction of depolymerization of beta-poly(L-malate) catalysed by polymalatase from Physarum polycephalum--fluorescence labeling at the carboxy-terminus of beta-poly(L-malate). Eur J Biochem (1997) 0.92
Adoptive immunotherapy in canine chimeras. Transplantation (1997) 0.92
Angiitis of the central nervous system after allogeneic bone marrow transplantation? Stroke (1999) 0.92
Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg (2000) 0.91
Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation. Neurology (2001) 0.91
Epidemiology of molluscum contagiosum using genetic analysis of the viral DNA. J Med Virol (1989) 0.91
Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis. Scand J Immunol (2007) 0.91
The reaction of platinum(II) complexes with DNA. Kinetics of intrastrand crosslink formation in vitro. Nucleic Acids Res (1991) 0.91
Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Br J Dermatol (2005) 0.90
Expression of IL-8 by cells of the odontoblast layer in vitro. Eur J Oral Sci (1999) 0.89
Cellular distribution and cellular reactivity of platinum (II) complexes. Biochem Pharmacol (1996) 0.89
[A review of the history of the departments of psychiatry and neurology, Vienna University (author's transl)]. Wien Klin Wochenschr (1974) 0.89
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol (2011) 0.88
Variations in 1 alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. Bone Marrow Transplant (2004) 0.88
Synthetic substrates and inhibitors of beta-poly(L-malate)-hydrolase (polymalatase). Eur J Biochem (2000) 0.88
Catalytic mechanism of phenylalanyl-tRNA synthetase of Escherichia coli K10. Conformational change and tRNAPhe phenylalanylation are concerted. Biochemistry (1982) 0.87
Modification of L-isoleucyl-tRNA synthetase with L-isoleucyl-bromomethyl ketone. The effect of the catalytic steps. Eur J Biochem (1977) 0.87
Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J Neuroimmunol (1996) 0.87
Ionizing radiation induces human intercellular adhesion molecule-1 in vitro. J Invest Dermatol (1994) 0.87
Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands. Scand J Immunol (2010) 0.87
Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. Blood (1997) 0.86
NKG2D-dependent effector function of bronchial epithelium-activated alloreactive T-cells. Eur Respir J (2008) 0.86
Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System. Bone Marrow Transplant (2012) 0.86
Molecular cloning and physical mapping of the genome of insect iridescent virus type 6: further evidence for circular permutation of the viral genome. Virology (1987) 0.85
Beta-poly(L-malate) production by non-growing microplasmodia of Physarum polycephalum. Effects of metabolic intermediates and inhibitors. FEMS Microbiol Lett (2000) 0.85
The catalytic mechanism of amino acid:tRNA ligases. Synergism and formation of the ternary enzyme-amino acid-ATP complex. Biochemistry (1975) 0.84
Expression of heme oxygenase-1 protects endothelial cells from irradiation-induced apoptosis. Endothelium (2005) 0.84
Phenylalanyl-tRNA synthetase induced conformational change of Escherichia coli tRNA phe. Biochemistry (1979) 0.84
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study. Bone Marrow Transplant (2011) 0.83
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. Bone Marrow Transplant (2006) 0.83
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation. Leukemia (2004) 0.83
Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease. Curr Pharm Des (2009) 0.83
Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy. Ann Oncol (2000) 0.83
L-phenylalanine:tRNA ligase of Escherichia coli K10. A rapid kinetic investigation of the catalytic reaction. Biochemistry (1975) 0.83
Phenylalanyl-tRNA synthetase from Escherichia coli K10. Synergistic coupling between the sites for binding of L-phenylalanine and ATP. Eur J Biochem (1973) 0.83
Outcome of hemato-oncologic patients with and without stem cell transplantation in a medical ICU. Eur J Med Res (2007) 0.83
Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation. Hum Immunol (2001) 0.82
Different types of human leukemias express the message for TNF-alpha and interleukin-10. Eur J Med Res (2001) 0.82
A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations. Leukemia (2005) 0.82
Effects of coordination of diammineplatinum(II) with DNA on the activities of Escherichia coli DNA polymerase I. Biochemistry (1988) 0.82
Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol (1998) 0.82
Active site stoichiometry of L-phenylalanine: tRNA ligase from Escherichia coli K(-10). J Biol Chem (1975) 0.82
Mapping of monoclonal antibodies to human factor IX. Blood (1989) 0.82
Characterization of human anti-factor VIII antibodies purified by immune complex formation. Blood (1976) 0.81
Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clin Exp Immunol (2009) 0.81
Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant (2005) 0.81
Transmural penetration of intravenously applied microbubbles during contrast-enhanced ultrasound as a new diagnostic feature in patients with GVHD of the bowel. Bone Marrow Transplant (2010) 0.81
Equilibrium analysis of L-Phe-tRNA Phe complexes with L-phenylalanyl transfer ribonucleic acid synthetase of Escherichia coli K 10. Biochemistry (1974) 0.81
Platinum compounds with estrogen receptor affinity. Cancer Treat Rev (1990) 0.81
Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant (1997) 0.81
Mode of inhibition of the DNA polymerase of Methanococcus vannielii by aphidicolin. Eur J Biochem (1987) 0.81
Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges. Transpl Infect Dis (2011) 0.81
Nuclear accumulation and homeostasis of the unusual polymer beta-poly (L-malate) in plasmodia of Physarum polycephalum. Eur J Cell Biol (1996) 0.80
Purification and characterization of DNA polymerase alpha from plasmodia of Physarum polycephalum. Eur J Biochem (1988) 0.80
Labelling of the catalytic site of lysozyme. Biochem Biophys Res Commun (1969) 0.80
Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center. Bone Marrow Transplant (2012) 0.79
Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplant (1994) 0.79
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation. Bone Marrow Transplant (1997) 0.79
Effect of growth factors on estrogen receptor mediated gene expression. J Steroid Biochem Mol Biol (1996) 0.79